

































Loss of function of Protein kinase A (PKA) mediates 
anti-aging effects 
 
PKA is an important mediator of signal transduction 
downstream of G-protein-coupled receptors and plays a 
key role in the regulation of metabolism and triglyceride 
storage. It is a ubiquitous cellular kinase that 
phosphorylates serine and threonine residues in 
response to cAMP [1]. PKA is dependent upon cAMP 
for functional activation.  Adenyl cyclase (AC) is an 
upstream regulator of cAMP and PKA.  PKA consists 
of two regulatory subunits and two catalytic subunits 
(Figure 1).  cAMP binds to the regulatory subunits, 
releasing the catalytic subunits which are then free to 
interact with and phosphorylate downstream targets.   
There are four isoforms of the regulatory subunit (RIα, 
RIβ, RIIα, RIIβ) and three types of catalytic subunits 
(Cα, Cβ, Cγ), each of which demonstrates different 
patterns of tissue expression and subcellular localization 




































male mice lacking the regulatory RIIβ subunit have 
extended lifespan and are also resistant to age-related 
conditions including cardiac decline [4], summarized in 
Table 1. There was no lifespan advantage seen in PKA 
RIIβ females. Young RIIβ null and WT littermates 
weigh about the same and have about the same amount 
of body fat and lean body mass, but with age, there is a 
striking difference in these parameters between the two 
genotypes for either gender. Both genotypes eat about 
the same amount, so the body composition differences 
cannot be attributed to differences in food intake.   RIIβ 
null males are more insulin sensitive that WT 
littermates, regardless of age, but old (17 mos) RIIβ null 
females are also extremely insulin sensitive compared 
to WT littermates, suggesting that this is not the 
physiological factor responsible for the longevity 
phenotype observed exclusively in males.   
 
In contrast, our data has shown that body composition, 
including body weight, percent body fat mass, and 
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WT C57/BL6J male, but not female mice [4] suggesting 
that body composition may be a physiological factor 
contributing to the difference in lifespan phenotypes 
between mutant males and females.   
 
Cardiac aging is delayed in PKA RIIβ null mutant 
mice 
 
 Echocardiographic parameters in mice, particularly left 
ventricular hypertrophy, diastolic dysfunction and 
impaired myocardial performance index, show 
progressive and highly reproducible changes with 
advancing age which parallel those of human aging [5]. 
Aging is accompanied by slowly progressive and 
irreversible structural changes and functional declines in 
the heart. Echocardiography in healthy populations 
from the Framingham Study and the Baltimore 
Longitudinal Study on Aging showed an age-dependent 
increase in the prevalence of left ventricular 
hypertrophy, a decline in diastolic function, and 
relatively preserved systolic function at rest but a 
decline in exercise capacity, as well as an increase in the 
prevalence of atrial fibrillation (reviewed in [6]). 
Diastolic heart failure, defined as symptoms of heart 
failure in the setting of diminished diastolic function, is 
pervasive in older individuals and markedly increases 
the risk of mortality [7]. Greater than half of indivi-
duals over the age of 75 with validated congestive 

























dividuals this was clinically unrecognized and 
untreated. Diastolic dysfunction is also a major 
contributor to exercise intolerance in the elderly 
population. An age-dependent impairment of 
myocardial performance index (MPI) has also been 
shown [8].  
 
Using echocardiography, we have seen cardiac 
dysfunction as early as 10-12 months of age in wild 
type C57BL/6 mice, which continually progresses with 
increasing age. Heart weights of young PKA RIIβ 
mutant mice are similar to WT littermates, but at 24 
months of age, mutants showed significantly lower left 
ventricular masses compared to WT mice [4].  Doppler 
imaging on these older mice, employed to measure the 
velocity of the mitral valve annulus,  isovolumic 
contraction and relaxation times and ejection times, also 
showed superior Ea/Aa ratios in the mutants, indicating 
a resistance to age-related diastolic dysfunction, and a 
lower average myocardial performance index (MPI) 
indicative of superior global ventricular function [8]. 
These observations indicate a cardiac protective affect 
of the RIIβ deletion and suggest a possible connection 
with the Yan et al. findings [9]  that the absence of AC5 
is protective of cardiac function.  The fact that RIIβ is 
not expressed, or expressed at very low levels in cardiac 
tissue suggests that signaling from adipose tissue or the 
brain may be involved.  It is also possible that the 
delayed cardiac function is a secondary effect due to 



















































PKA plays multiple roles in heart function. Its 
phosphorylation in the cardiac myocyte regulates many 
processes including contraction, metabolism, ion fluxes, 
and the transcription of many different genes [10]. 
Altered PKA signaling has been implicated in a number 
of physiological problems leading to cardiomyopathy.   
For example, the onset of cardiac hypertrophy is 
influenced by alterations in muscle-specific A-kinase 
Anchoring Protein (mAKAP) signaling in myocytes. 
AKAPs bind to PKA regulatory subunits such as RIIβ, 
in order to subcellularly localize and modulate 
interactions between PKA and its downstream targets 
[11].  PKA is also involved in the downstream 
regulation of the β-adrenergic pathway. Stimulation of 
β-adrenergic receptors (β-ARs) in the heart leads to the 
PKA-dependent phosphorylation of multiple 
intracellular targets in cardiac myocytes including the 
L-type Ca2
+ channel in the sarcolemma, the ryanodine 
receptor (RyR2), and phospholamban in the 
sarcoplasmic reticulum [12, 13]. Deficiencies in this 
pathway have been linked to increased baseline myo-
fibrillar Ca2+ sensitivity and subsequent cardio-
myopathy in humans, due to reduced phosphorylation of 
downstream targets such as cardiac troponin I [14]. The 
β-adrenergic pathway is known to be enhanced in RIIβ 
null mice [15], which could help provide a possible 
mechanism for the cardiac sparing effects in seen in 
these mice.  Paradoxically, activated βAR signaling has 
also been implicated in the failing heart.  Chronic heart 
failure is associated with an increase in circulating 
catecholamines [16], PKA phosphorylation of RyR2 is 
markedly increased in failing human hearts [17], and 
mice with constitutive activation of PKA show 
hyperphosphorylation of RyR2 and dilated 




















Phenotype Males Females 
Lifespan 
 
Extended No  extension 
















targets of PKA and how they affect cardiac function in 
aged RIIβ null mice will be a productive area of aging 
research. 
 
Deletion of the Cβ catalytic subunit of PKA results 
in delayed aging 
  
We have studied PKA catalytic Cß subunit null mutant 
mice to establish correlations with age-delaying benefits 
[18].  Female PKA Cß null mice fed a high caloric diet 
(HCD) showed robust obesity resistance. The 
significant increase in body weight in wild type 
littermates was shown by quantitative magnetic 
resonance (QMR) imaging to be due to an increase in 
fat mass.  Generally, there was no difference in the 
amount of food consumed by either genotype.  When 
individual fat depots were weighed there was a sparing 
effect in visceral fat in both female and male PKA Cß 
null mice consistent with observations indicating that 
accumulation of visceral fat is a high risk factor for age-
related disease. Mutants of both genders also showed 
dramatic fat sparing effects in the liver, showing that 
PKA Cß null mice are resistant to the hepatic steatosis-
like condition associated with ingesting a high caloric 
diet. Blood glucose was elevated in wild type 
littermates, but not PKA Cß null mice, as early as 4 
weeks on the HCD.  A glucose tolerance test showed 
that PKA Cß null mice on a HCD maintain their 
tolerance to glucose in contrast to wild type littermates. 
Hyperinsulinemia was seen as early as seven weeks into 
the HCD diet in wild type littermates, but not in PKA 
Cß null mice.  An insulin sensitivity test showed that 
PKA Cß null mice do not develop insulin resistance 
associated with the high caloric diet as wild type 
littermates do.   
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In addition to being protected from diet-induced 
pathologies, PKA Cβ null mutant mice are protected 
from age-related problems such as weight gain and 
enlarged livers, as well as cardiac dysfunction and 
hypertrophy.  As with RIIβ, we have used echocardio-
graphy and doppler imaging to look at diastolic function 
and myocardial performance index, and have found 
superior Ea/Aa ratios and MPIs in the mutants 
compared to WT as early as 9 months of age, 
continuing up to 24 months of age.  By 24 months, we 
have observed other evidence of worsening diastolic 
function in WT mice, including significantly higher 
injection response times, reduced fractional shortening 
percentages, and enlarged left atria compared to 
mutants.  By end of life, we have found that WT mice 
have significantly larger hearts than littermates lacking 
PKA Cβ (manuscript in preparation).  The mechanisms 
for these observations are not known since PKA Cβ is 
detectable only at very low levels in cardiac tissue of 




































liver and could help provide a correlation with cardiac 
protective effects since PKA has been shown to 
phosphorylate and inactivate AMPKα in order to 
regulate the activity of lipolytic enzymes such as 
hormone-sensitive lipase [19].  Increases in AMPKα  
have been linked to fatty liver resistance, as well as a 
reduction in cardiac protein synthesis and delayed 
hypertrophy [20, 21].  Interestingly, we have data to 
show that Cβ null mice have increased levels of 
phosphorylated AMPK.  Transcription of the gene for 
carboyhydrate-response-element-binding protein 
ChREBP, a master regulator of lipid metabolism, is 
known to be AMPK-mediated, and we have found that 
levels of this protein are lower in livers of PKA Cβ 
disrupted mice.  Increased fatty acid oxidation and 
lipolysis, and decreased fatty acid and protein 
synthesis through the AMPK pathway may be possible 
mechanisms by which PKA Cβ disruption leads to 
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discrete neural expression of Cβ variants hints at a 
specific functional role in neuronal signaling. 
Disruption of Cβ causes a 26% decrease in basal 
PKA activity in the brain despite a reported 
compensatory increase in the amount of Cα protein 
[22]. While the catalytic subunits Cα and Cβ are 91% 
identical in amino acid sequence, their amino acid 
differences are highly conserved across species and 
they are thus believed to have unique functions [23]. 
Therefore, a shift from Cβ to Cα activity may still 
represent an increase in a particular type of PKA 
catalytic function.  Since our current studies suggest 
that PKA Cβ null mice are leptin sensitive, one 
possibility is an enhanced response to the activation 
of leptin-sensitive melanocortin receptors, resulting 
in increased energy expenditure compared to WT. 
The arcuate nucleus region of the hypothalamus 
contains leptin-responsive neurons that control 
feeding and energy expenditure through the 
activation of Gs-coupled melanocortin receptors.   
These receptors are thought to decrease food intake 
and increase energy expenditure through stimulation 
of the cAMP pathway and activation of PKA [24]. 
The implications for aging are highly relevant since 
aging is known to be characterized by a decline in 
metabolic function, and is associated with resistance 
to the effects of leptin on the modulation of fat 
accumulation and distribution [25].  Interestingly, the 
AMPK pathway is also stimulated by leptin [26], 
suggesting another potential mechanism by which 
leptin sensitivity caused by deletion of PKA Cβ 
might lead to the obesity, fatty liver, and heart 
disease resistance phenotypes observed in our mice 
(Figure 2).  
 
PKA subunit genes are potential anti-aging targets 
 
Since PKA is a major metabolic regulator of gene 
signaling, the human gene homologs are potential 
pharmacological targets for age-related conditions. 
Therefore, our studies in the mouse are directly 
applicable to advancing new knowledge in the 
treatment and prevention of diseases associated with 
progressive aging [27]. The heart would appear to be 
an excellent PKA inhibitory target since PKA null 
mutant mice are robustly protected from age-related 
cardiac decline.  Through the mouse models we have 
characterized, we hope to explore several possible 
mechanisms that may explain the positive health 
benefits of PKA inactivation or down-regulation. 
Studies on PKA subunit genes can be carried out and 
confirmed to more specially define the intervention 
targets and realistically predict biological outcomes in 
human clinical trials.   
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